Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous lidocaine for prevention and reduction of postoperative ileus after elective colorectal surgery
ACTRN12618000123246Phase 3Not yet recruiting
- Sponsor
- University of Otago
- Start
- Feb 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of lidocaine in postoperative ileus (POI) (2 arms), sponsored by University of Otago. Primary endpoint: Duration of postoperative ileus. Planned start Feb 2018; status: not yet recruiting.
02
Drugs
lidocaine
03
Conditions
postoperative ileus (POI)
Beyond the preview
Go deeper on ACTRN12618000123246.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12618000123246.